PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsChronic hepatitis b
MeSH D019694 - chronic hepatitis b
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006509:Hepatitis b
41 Companies
17 Drugs
$
Success rate
D006521:Chronic hepatitis
0 Companies
0 Drugs
Success rate
D019694: 
Chronic hepatitis b
34 Companies
17 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
55%
21/38
Phase 2
65%
30/46
Phase 3
70%
28/40
Approved: 12Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Emtricitabine,
Tenofovir disoproxil,
Efavirenz,
Lamivudine,
Tenofovir,
Fendrix
Johnson & Johnson
Tenofovir alafenamide,
Cobicistat,
Emtricitabine,
Darunavir,
Cetrelimab,
Tenofovir,
Sodium chloride,
Bevifimod,
Fendrix,
Arm1,
Arm2
GSK
Lamivudine,
Benzocaine,
Alanine,
Tenofovir,
Adefovir,
Carmellose,
Bepirovirsen,
Carboxymethylcellulose,
Sodium chloride,
Albinterferon alfa-2b,
Bevifimod,
Nadide,
Microcrystalline cellulose,
Fendrix,
Gsk3965193,
Arm1,
Hepsera,
Arm2,
Gsk3389404
Roche
Ribavirin,
Peginterferon alfa-2a,
Methionine,
Tenofovir,
Thymalfasin,
Adefovir,
Sodium chloride,
Albinterferon alfa-2b,
Aspartame,
Bevifimod,
Ro7565020,
Fendrix,
Ro7239958,
Arm1,
Hepsera,
Arm2,
Ro6864018,
Ro7062931
Novartis
Telbivudine,
Benzocaine,
Tenofovir,
Adefovir,
Albinterferon alfa-2b,
Valine,
VALTORCITABINE,
Fendrix,
Arm1,
Hepsera,
Arm2,
Evidence
Merck & Co
Interferon alfa-2b,
Doravirine,
Tenofovir disoproxil,
Lamivudine,
Vitamin e,
Vaniprevir,
Alanine,
Vicriviroc,
Tenofovir,
Alfacalcidol,
Adefovir,
Albinterferon alfa-2b,
Aspartame,
SAMATASVIR,
Fendrix,
Antacid,
Hepsera,
IDX184,
Evidence,
IDX719
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use